FR

Merck Sante


USPTO Granted Patents = 5

% Expired Patents = 60.0


Trademarks = 2

Forward Citations = 17

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Gérard Moinet (2 out of 26 patents)

silverMedal Micheline R Kergoat (2 out of 25 patents)

bronzeMedal Didier Mesangeau (2 out of 13 patents)

4.  Daniel Cravo (2 out of 26 patents)

5.  Liliane Doare (2 out of 12 patents)

6.  Marc Lecomte (1 out of 3 patents)

7.  Ulriche Denis (1 out of 1 patent)

8.  Clarisse Paget (1 out of 1 patent)

9.  Nicolas Wiernsperger (1 out of 2 patents)

10.  Yves Bonhomme (1 out of 15 patents)

11.  Sophie Tartare-Deckert (1 out of 1 patent)

12.  Emmanuel Van Obberghen (1 out of 1 patent)

13.  Geoffrey Nicholson (1 out of 2 patents)

14.  Michel Lagarde (1 out of 3 patents)

15.  Gillian Cave (1 out of 1 patent)


5 patents:

Company Overview
Merck Sante is a leading pharmaceutical company committed to improving the health and well-being of people around the world. With a focus on research and innovation, Merck Sante develops and markets a wide range of healthcare products and services, including prescription medicines, vaccines, and over-the-counter remedies. Through partnerships with healthcare professionals and organizations, Merck Sante strives to address the diverse needs of patients and promote a healthier future for all.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#191 in

#2,863 in France

FR
FR
Forward Citations = 17

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Merck Sante. Retrieved from https://idiyas.com/company/merck-sante

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…